In the future, the ideal steak will be sizzling, charbroiled – and probably made from cultivated meat. However, companies that produce cell-based meat are challenged to make production affordable.
Recently, researchers at Israel’s Weizmann Institute of Science stumbled upon a solution that could cut the cost of cultivated meat in half.
Read more here.
![[Biolojic in BioSpace] Interim results from phase 1/2 clinical trial in solid tumor cancers demonstrate Aulos Bioscience’s AU-007 is well tolerated and uniquely reduces regulatory T Cells](https://blog.ourcrowd.com/wp-content/themes/Extra/images/post-format-thumb-text.svg)
